Does the HeartMate II continuous-flow left ventricular assist device improve renal and hepatic function in advanced heart failure patients bridged to transplantation?
Continuous-flow LVAD support with HeartMate II improves renal and hepatic function in advanced heart failure patients awaiting transplant over 6 months.
The HeartMate II continuous-flow left ventricular assist device improves renal and hepatic function in advanced heart failure patients who are being bridged to transplantation, without evidence of detrimental effects from reduced pulsatility over a 6-month time period.
Russell et al. (Tue,) studied this question.